Recall StatusOpen, Classified
Date Initiated2026-06-17
Product Quantity1079
Reason for Recall
Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.
Firm Action
On 6/17/2026, removal notices were mailed and emailed to customers informing them of the following:
1) Stop further use or distribution and segregate affected product.
2) Complete and return the Reply Verification Tracking Form via email to
[email protected]
3) Return affected devices to firm.
4) Share this communication with any healthcare professionals in your facility that use the product and with any other organization to which these systems may have been transferred.
Report any adverse events or quality concerns associated with use of these devices to firm via email at
[email protected]
This removal of unused Infinion CX Leads is part of the planned transition to the next generation lead (Infinion Pro).
Distribution Pattern
US: NY.
OUS: Canada, Portugal, Spain, France, Netherlands, Great Britain, Italy, Israel, Serbia, Greece, Germany, United Arab Emirates, Ireland, Hungary, Czech Republic, Brazil, Colombia, Argentina
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.